MEDIVIR
Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. Medivir is a protease inhibitor design and the nucleotide/nucleoside science and we are dedicated to developing innovative pharmaceuticals that meet a great unmet medical need. Our commercial organization provides a portfolio of specialty care, pharmaceuticals on the Nordic market.
MEDIVIR
Industry:
Biotechnology Pharmaceutical
Founded:
1988-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.medivir.com
Total Employee:
101+
Status:
Active
Contact:
+46 (0)85-468-3100
Email Addresses:
[email protected]
Total Funding:
30.8 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-04-12 | Biophausia AB | Biophausia AB acquired by Medivir | 62 M EUR |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-25 | Medivir Appoints Jens Lindberg as Chief Executive Officer |
| 2020-10-05 | Medivir appoints Dr. Tom Morris as interim Chief Medical Officer |
| 2020-05-26 | Medivir appoints Yilmaz Mahshid as new CEO |
Official Site Inspections
http://www.medivir.com
- Host name: 104.19.191.28
- IP address: 104.19.191.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
